Phase I Clinical Trial of GRID Therapy in Pediatric Osteosarcoma of the Extremity
| Status: | Recruiting |
|---|---|
| Conditions: | Other Indications |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 5 - 21 |
| Updated: | 9/21/2018 |
| Start Date: | July 25, 2017 |
| End Date: | June 2020 |
| Contact: | Sandy Annis, BA |
| Email: | amannis@uams.edu |
| Phone: | 5016868274 |
The primary objective of this study is to evaluate the toxicity profile of GRID therapy using
dose levels of 10Gy, 15 Gy and 20Gy in pediatric osteosarcoma of the extremity.
dose levels of 10Gy, 15 Gy and 20Gy in pediatric osteosarcoma of the extremity.
Subjects will receive GRID radiotherapy. GRID radiation therapy is considered a standard
radiation therapy method however is not typically used in pediatric osteosarcoma patients.
This protocol will evaluate whether or not the use of this therapy will provide benefit to
this patient population.
radiation therapy method however is not typically used in pediatric osteosarcoma patients.
This protocol will evaluate whether or not the use of this therapy will provide benefit to
this patient population.
Inclusion Criteria:
- History of cytological or histological documentation of non-metastatic extremity
osteosarcoma.
- 5-21 years of age.
- Subject is eligible for routine chemotherapy and routine surgery for the treatment of
non-metastatic extremity osteosarcoma
- Informed consent is obtained
Exclusion Criteria:
- Females with a positive urine pregnancy test.
- Unable to comply with study procedures
We found this trial at
1
site
529 West Markham Street
Little Rock, Arkansas 72205
Little Rock, Arkansas 72205
(501) 686-7000
Phone: 501-686-7284
University of Arkansas for Medical Sciences The University of Arkansas for Medical Sciences (UAMS) in...
Click here to add this to my saved trials
